Pharmaceutical R&D and the Evolving Market for Drugs (PDF; 602 KB)
Source: Congressional Budget Office
From CBO Director’s blog:

Investment in research and development (R&D) over the past several decades has produced a wealth of valuable new drug therapies. Current and future pharmaceutical R&D will determine what drug therapies will become available, and thus will influence future health-care costs. Yesterday CBO released a brief that describes the state of investment in drug R&D and the factors that influence it. It also examines how various policy options to control the growth in health care costs or to expand insurance coverage could affect spending on R&D.

This entry was posted on Monday, November 2nd, 2009 at 12:36 am and is filed under Business and economics, Government and politics, Prescription drugs, Science. You can follow any responses to this entry through the RSS 2.0 feed. Responses are currently closed, but you can trackback from your own site.